PAPER Kawas CH, Greenia DE, Bullain SS, Clark CM, Pontecorvo MJ, Joshi AD, Corrada MM
SEARCH RESULTS
330907 RESULTS
PAPER Ting SK, Hameed S, Earnest A, Tan EK
Dissociative semantic breakdown in Alzheimer's disease: Evidence from multiple category fluency test.
Clin Neurol Neurosurg. 2012 Nov 16; PubMed: 23164607PAPER Rizzo S, Tarozzi A, Bartolini M, da Costa G, Bisi A, Gobbi S, Belluti F, Ligresti A, Allarà M, Monti JP, Andrisano V, Di Marzo V, Hrelia P, Rampa A
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents.
Eur J Med Chem. 2012 Dec;58:519-32. PubMed: 23164658PAPER O'Hare E, Scopes DI, Kim EM, Palmer P, Jones M, Whyment AD, Spanswick D, Amijee H, Nerou E, McMahon B, Treherne JM, Jeggo R
Orally bioavailable small molecule drug protects memory in Alzheimer's disease models.
Neurobiol Aging. 2013 Apr;34(4):1116-25. PubMed: 23164690PAPER Brown BM, Peiffer JJ, Martins RN
Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer's disease?
Mol Psychiatry. 2012 Nov 20; PubMed: 23164816PAPER Killick R, Ribe EM, Al-Shawi R, Malik B, Hooper C, Fernandes C, Dobson R, Nolan PM, Lourdusamy A, Furney S, Lin K, Breen G, Wroe R, To AW, Leroy K, Causevic M, Usardi A, Robinson M, Noble W, Williamson R, Lunnon K, Kellie S, Reynolds CH, Bazenet C, Hodges A, Brion JP, Stephenson J, Paul Simons J, Lovestone S
Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway.
Mol Psychiatry. 2012 Nov 20; PubMed: 23164821PAPER Ma YQ, Wu DK, Liu JK
mTOR and tau phosphorylated proteins in the hippocampal tissue of rats with type 2 diabetes and Alzheimer's disease.
Mol Med Report. 2013 Feb;7(2):623-7. PubMed: 23165862PAPER Cartz Piver L, Nubukpo P, Faure A, Dumoitier N, Couratier P, Clément JP
Describing perceived stigma against Alzheimer's disease in a general population in France: the STIG-MA survey.
Int J Geriatr Psychiatry. 2012 Nov 20; PubMed: 23166060PAPER Müller S, Saur R, Greve B, Melms A, Hautzinger M, Fallgatter AJ, Leyhe T
Recognition performance differentiates between elderly patients in the long term course of secondary progressive multiple sclerosis and amnestic mild cognitive impairment.
Mult Scler. 2012 Nov 19; PubMed: 23166118PAPER Ritchie CW, Ritchie K
The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease.
BMJ Open. 2012;2(6) PubMed: 23166135PAPER Kiko T, Nakagawa K, Satoh A, Tsuduki T, Furukawa K, Arai H, Miyazawa T
Amyloid β levels in human red blood cells.
PLoS One. 2012;7(11):e49620. PubMed: 23166730PAPER Ossenkoppele R, Prins ND, Pijnenburg YA, Lemstra AW, van der Flier WM, Adriaanse SF, Windhorst AD, Handels RL, Wolfs CA, Aalten P, Verhey FR, Verbeek MM, van Buchem MA, Hoekstra OS, Lammertsma AA, Scheltens P, van Berckel BN
Impact of molecular imaging on the diagnostic process in a memory clinic.
Alzheimers Dement. 2012 Nov 16; PubMed: 23164552PAPER Kingwell K
Alzheimer disease: New insights into preclinical Alzheimer disease.
Nat Rev Neurol. 2013 Jan;9(1):4. PubMed: 23165336PAPER Landau SM, Breault C, Joshi AD, Pontecorvo M, Mathis CA, Jagust WJ, Mintun MA,